Literature DB >> 12093417

Estimating the cost of unmet HIV-prevention needs in the United States.

David R Holtgrave1, Steven D Pinkerton, Michael Merson.   

Abstract

BACKGROUND: Although new HIV infection cases have dropped from over 160,000 per year in the mid-1980s to 40,000 per year in the 1990s, HIV incidence has been relatively unchanged for a decade. This number of annual incident infections suggests that substantial, unmet HIV-prevention needs continue to fuel the HIV epidemic in the United States.
OBJECTIVES: This study estimates the cost of addressing the unmet HIV-prevention needs in the United States and establishes a performance standard by estimating the number of HIV infections that would have to be prevented in order for these programs to be considered cost saving to society.
METHODS: Standard methods of cost and threshold analysis were employed in this study. Interventions needed to address unmet behavioral risks include services to reduce sexual risk of HIV infection, services to provide access to sterile syringes for people who cannot stop injecting drugs, HIV counseling and testing, and intensive preventive services to help HIV-seropositive people avoid transmitting the virus to others.
RESULTS: If brief interventions are utilized to address sexual behavior risk, the total program cost (over and above current resource levels) is just over $817 million; and if more expensive multisession, small-group interventions are used, the costs increase to over $1.85 billion. However, even the higher-cost program has a threshold of only 12,000 infections that must be prevented in order for the program to be considered a cost saving to society.
CONCLUSIONS: Addressing the remaining unmet HIV-preventive needs in the United States will require a substantial commitment of resources. However, even a greatly expanded HIV-preventive program in the United States could pay for itself through savings in averted medical care costs.

Entities:  

Mesh:

Year:  2002        PMID: 12093417     DOI: 10.1016/s0749-3797(02)00447-6

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  8 in total

1.  Providers' perceptions of and receptivity toward evidence-based HIV prevention interventions.

Authors:  Jill Owczarzak; Julia Dickson-Gomez
Journal:  AIDS Educ Prev       Date:  2011-04

2.  Testing for HIV infection in the United States.

Authors:  Lindsey L Wolf; Rochelle P Walensky
Journal:  Curr Infect Dis Rep       Date:  2007-01       Impact factor: 3.725

3.  The magnitude of key HIV prevention challenges in the United States: implications for a new national HIV prevention plan.

Authors:  David R Holtgrave; Jean Flatley McGuire; Jesse Milan
Journal:  Am J Public Health       Date:  2007-05-30       Impact factor: 9.308

4.  When "heightened" means "lessened": the case of HIV prevention resources in the United States.

Authors:  David R Holtgrave
Journal:  J Urban Health       Date:  2007-09       Impact factor: 3.671

5.  Preliminary program evaluation of emergency department HIV prevention counseling.

Authors:  Andrea P Sitlinger; Christopher J Lindsell; Andrew H Ruffner; D Beth Wayne; Kimberly W Hart; Alexander T Trott; Carl J Fichtenbaum; Michael S Lyons
Journal:  Ann Emerg Med       Date:  2011-07       Impact factor: 5.721

6.  Costs of HIV prevention among out-of-treatment drug-using women: results of a randomized controlled trial.

Authors:  Jennifer Prah Ruger; Arbi Ben Abdallah; Linda Cottler
Journal:  Public Health Rep       Date:  2010 Jan-Feb       Impact factor: 2.792

7.  The cost-effectiveness of counseling strategies to improve adherence to highly active antiretroviral therapy among men who have sex with men.

Authors:  Gregory S Zaric; Ahmed M Bayoumi; Margaret L Brandeau; Douglas K Owens
Journal:  Med Decis Making       Date:  2008-03-18       Impact factor: 2.583

8.  Cost savings threshold analysis of a capacity-building program for HIV prevention organizations.

Authors:  Kim Nichols Dauner; Willie H Oglesby; Donna L Richter; Christopher M LaRose; David R Holtgrave
Journal:  AIDS Educ Prev       Date:  2008-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.